enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
7.76
+0.16 (2.11%)
Apr 15, 2026, 4:00 PM EDT - Market closed
enGene Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$21.08
Upside
+171.65%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| WBB Securities | WBB Securities | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +177.06% | Apr 13, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $33 → $30 | Buy | Maintains | $33 → $30 | +286.60% | Mar 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +222.16% | Mar 9, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $18 → $19 | Buy | Maintains | $18 → $19 | +144.85% | Nov 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $30 → $33 | Buy | Reiterates | $30 → $33 | +325.26% | Nov 12, 2025 |
| UBS | UBS | Hold Maintains $4 → $10 | Hold | Maintains | $4 → $10 | +28.87% | Nov 12, 2025 |
| Citizens | Citizens | Buy Maintains $18 → $21 | Buy | Maintains | $18 → $21 | +170.62% | Nov 12, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +131.96% | Sep 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +222.16% | Sep 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +222.16% | Sep 8, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +131.96% | Apr 29, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $37 → $34 | Buy | Maintains | $37 → $34 | +338.14% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +222.16% | Mar 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $26 | Buy | Initiates | $26 | +235.05% | Feb 18, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $34 → $7 | Strong Buy → Hold | Downgrades | $34 → $7 | -9.79% | Feb 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +131.96% | Dec 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.